Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma

NCT04356170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Head and Neck

Interventions

DRUG: Docetaxel
DRUG: Cisplatin
DRUG: Fluoro Uracil

Sponsor

Groupe Oncologie Radiotherapie Tete et Cou

Collaborators

[object Object]